长春高新：聚焦内分泌代谢等传统优势领域与创新方向，逾40种候选药物处于临床阶段或已提交IND

Core Viewpoint - The company is focused on enhancing its core competitiveness by concentrating on traditional areas such as endocrine metabolism and women's health, as well as innovative directions related to oncology, respiratory, and immunology [1] Product Development - The company is steadily advancing the research and development of products with differentiation and global market potential, with over 40 candidate drugs currently in clinical stages or having submitted Investigational New Drug (IND) applications [1]